Trial Outcomes & Findings for Impact of Teledermatology on Health Services Outcomes in the Department of Veterans Affairs (NCT NCT00488293)

NCT ID: NCT00488293

Last Updated: 2015-06-08

Results Overview

Skindex-16 Change Scores. Skindex-16 is a quality of life measure that assesses "bother." It includes the domains of symptoms, emotions, and functioning. A composite (total) score can also be calculated. The range of scores are 0 (never bothered) to 100 (always bothered) for subscale and composite scores. A negative change score represents a better quality of life. A change score of 10 points is considered clinically significant.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

392 participants

Primary outcome timeframe

Baseline to Month 9

Results posted on

2015-06-08

Participant Flow

Recruitment occurred between 2008 and 2011.

Participant milestones

Participant milestones
Measure
Teledermatology Referrals
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
Conventional consult process Conventional consult process: Standard electronic consult
Overall Study
STARTED
196
196
Overall Study
COMPLETED
160
166
Overall Study
NOT COMPLETED
36
30

Reasons for withdrawal

Reasons for withdrawal
Measure
Teledermatology Referrals
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
Conventional consult process Conventional consult process: Standard electronic consult
Overall Study
Lost to Follow-up
28
25
Overall Study
Withdrawal by Subject
5
3
Overall Study
Death
2
1
Overall Study
Misrandomization/Other Unspecified
1
1

Baseline Characteristics

Impact of Teledermatology on Health Services Outcomes in the Department of Veterans Affairs

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Teledermatology Referrals
n=195 Participants
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=196 Participants
Conventional consult process Conventional consult process: Standard electronic consult
Total
n=391 Participants
Total of all reporting groups
Age, Continuous
61.7 years
STANDARD_DEVIATION 14.9 • n=5 Participants
62.9 years
STANDARD_DEVIATION 13.9 • n=7 Participants
62.3 years
STANDARD_DEVIATION 14.4 • n=5 Participants
Sex: Female, Male
Female
5 Participants
n=5 Participants
4 Participants
n=7 Participants
9 Participants
n=5 Participants
Sex: Female, Male
Male
190 Participants
n=5 Participants
192 Participants
n=7 Participants
382 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
2 Participants
n=7 Participants
2 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
193 Participants
n=5 Participants
191 Participants
n=7 Participants
384 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline to Month 9

Population: Baseline to Month 9 Skindex-16 change scores - Composite Score.

Skindex-16 Change Scores. Skindex-16 is a quality of life measure that assesses "bother." It includes the domains of symptoms, emotions, and functioning. A composite (total) score can also be calculated. The range of scores are 0 (never bothered) to 100 (always bothered) for subscale and composite scores. A negative change score represents a better quality of life. A change score of 10 points is considered clinically significant.

Outcome measures

Outcome measures
Measure
Teledermatology Referrals
n=160 Participants
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=164 Participants
Conventional consult process Conventional consult process: Standard electronic consult
Skindex-16 Change Scores Between Baseline to Month 9 - Composite Score
-12.0 units on a scale
Standard Deviation 24.5
-13.2 units on a scale
Standard Deviation 21.6

PRIMARY outcome

Timeframe: Baseline to Month 3

Population: Baseline to Month 3 Skindex-16 change scores - Composite Score

Skindex-16 Change Scores. Skindex-16 is a quality of life measure that assesses "bother." It includes the domains of symptoms, emotions, and functioning. A composite (total) score can also be calculated. The range of scores are 0 (never bothered) to 100 (always bothered) for subscale and composite scores. A negative change score represents a better quality of life. A change score of 10 points is considered clinically significant.

Outcome measures

Outcome measures
Measure
Teledermatology Referrals
n=161 Participants
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=171 Participants
Conventional consult process Conventional consult process: Standard electronic consult
Skindex-16 Change Scores Baseline to Month 3 - Composite Score
-7.8 units on a scale
Standard Deviation 21.9
-5.8 units on a scale
Standard Deviation 19.1

PRIMARY outcome

Timeframe: Baseline to Month 9

Population: Baseline to Month 9 Skindex-16 change scores - Symptoms Score

Skindex-16 Change Scores. Skindex-16 is a quality of life measure that assesses "bother." It includes the domains of symptoms, emotions, and functioning. A composite (total) score can also be calculated. The range of scores are 0 (never bothered) to 100 (always bothered) for subscale and composite scores. A negative change score represents a better quality of life. A change score of 10 points is considered clinically significant.

Outcome measures

Outcome measures
Measure
Teledermatology Referrals
n=159 Participants
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=164 Participants
Conventional consult process Conventional consult process: Standard electronic consult
Skindex-16 Change Scores Baseline to Month 9 - Symptoms Score
-10.3 units on a scale
Standard Deviation 30.6
-14.4 units on a scale
Standard Deviation 28.2

PRIMARY outcome

Timeframe: Baseline to Month 3

Population: Baseline to Month 3 Skindex-16 change score - Symptoms Score

Skindex-16 Change Scores. Skindex-16 is a quality of life measure that assesses "bother." It includes the domains of symptoms, emotions, and functioning. A composite (total) score can also be calculated. The range of scores are 0 (never bothered) to 100 (always bothered) for subscale and composite scores. A negative change score represents a better quality of life. A change score of 10 points is considered clinically significant.

Outcome measures

Outcome measures
Measure
Teledermatology Referrals
n=160 Participants
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=171 Participants
Conventional consult process Conventional consult process: Standard electronic consult
Skindex-16 Changes Scores Baseline to Month 3 - Symptoms Score
-8.7 units on a scale
Standard Deviation 29.8
-8.0 units on a scale
Standard Deviation 22.9

PRIMARY outcome

Timeframe: Baseline to Month 9

Population: Baseline to Month 9 Skindex-16 change score - Emotions Score

Skindex-16 Change Scores. Skindex-16 is a quality of life measure that assesses "bother." It includes the domains of symptoms, emotions, and functioning. A composite (total) score can also be calculated. The range of scores are 0 (never bothered) to 100 (always bothered) for subscale and composite scores. A negative change score represents a better quality of life. A change score of 10 points is considered clinically significant.

Outcome measures

Outcome measures
Measure
Teledermatology Referrals
n=160 Participants
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=164 Participants
Conventional consult process Conventional consult process: Standard electronic consult
Skindex-16 Change Scores Between Baseline and Month 9 - Emotions Score
-19.7 units on a scale
Standard Deviation 30.7
-18.1 units on a scale
Standard Deviation 25.1

PRIMARY outcome

Timeframe: Baseline to Month 3

Population: Baseline to Month 3 Skindex-16 change scores - Emotions Score

Skindex-16 Change Scores. Skindex-16 is a quality of life measure that assesses "bother." It includes the domains of symptoms, emotions, and functioning. A composite (total) score can also be calculated. The range of scores are 0 (never bothered) to 100 (always bothered) for subscale and composite scores. A negative change score represents a better quality of life. A change score of 10 points is considered clinically significant.

Outcome measures

Outcome measures
Measure
Teledermatology Referrals
n=160 Participants
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=171 Participants
Conventional consult process Conventional consult process: Standard electronic consult
Skindex-16 Change Scores Between Baseline to Month 3 - Emotions Score
-11.6 units on a scale
Standard Deviation 27.2
-8.9 units on a scale
Standard Deviation 25.3

PRIMARY outcome

Timeframe: Baseline to Month 9

Population: Baseline to Month 9 Skindex-16 change scores - Functioning Scores

Skindex-16 Change Scores. Skindex-16 is a quality of life measure that assesses "bother." It includes the domains of symptoms, emotions, and functioning. A composite (total) score can also be calculated. The range of scores are 0 (never bothered) to 100 (always bothered) for subscale and composite scores. A negative change score represents a better quality of life. A change score of 10 points is considered clinically significant.

Outcome measures

Outcome measures
Measure
Teledermatology Referrals
n=160 Participants
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=164 Participants
Conventional consult process Conventional consult process: Standard electronic consult
Skindex-16 Change Scores Between Baseline and Month 9 - Functioning Scores
-6.0 units on a scale
Standard Deviation 24.5
-6.9 units on a scale
Standard Deviation 22.3

PRIMARY outcome

Timeframe: Baseline to Month 3

Population: Baseline to Month 3 Skindex-16 change scores - Functioning Scores

Skindex-16 Change Scores. Skindex-16 is a quality of life measure that assesses "bother." It includes the domains of symptoms, emotions, and functioning. A composite (total) score can also be calculated. The range of scores are 0 (never bothered) to 100 (always bothered) for subscale and composite scores. A negative change score represents a better quality of life. A change score of 10 points is considered clinically significant.

Outcome measures

Outcome measures
Measure
Teledermatology Referrals
n=160 Participants
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=164 Participants
Conventional consult process Conventional consult process: Standard electronic consult
Skindex-16 Change Scores Between Baseline and Month 3 - Functioning Score
-3.2 units on a scale
Standard Deviation 20.2
-0.5 units on a scale
Standard Deviation 20.9

SECONDARY outcome

Timeframe: Baseline to Month 9

Population: Clinical course rating between baseline and month 9

Clinical course was assessed by review of serial digital images. The clinical course rating was provided by consensus opinion provided by a panel of three dermatologists that were not otherwise involved in the study. The rating categories were resolved, improved, unchanged - not clinically relevant, unchanged - clinically relevant, and worse.

Outcome measures

Outcome measures
Measure
Teledermatology Referrals
n=125 Participants
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=136 Participants
Conventional consult process Conventional consult process: Standard electronic consult
Clinical Course Rating Between Baseline and Month 9
Improved
59 participants
63 participants
Clinical Course Rating Between Baseline and Month 9
Unchanged - Not Clinically Relevant
13 participants
15 participants
Clinical Course Rating Between Baseline and Month 9
Unchanged - Clinically Relevant
13 participants
17 participants
Clinical Course Rating Between Baseline and Month 9
Worse
9 participants
6 participants
Clinical Course Rating Between Baseline and Month 9
Resolved
31 participants
35 participants

SECONDARY outcome

Timeframe: Baseline to First Clinic Visit

Population: Clinical course rating between baseline and first clinic visit, if a visit occurred. Timeframe varied and only applied if a first clinic visit occurred.

Clinical course was assessed by review of serial digital images. The clinical course rating was provided by consensus opinion provided by a panel of three dermatologists that were not otherwise involved in the study. The rating categories were resolved, improved, unchanged - not clinically relevant, unchanged - clinically relevant, and worse.

Outcome measures

Outcome measures
Measure
Teledermatology Referrals
n=94 Participants
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=137 Participants
Conventional consult process Conventional consult process: Standard electronic consult
Clinical Course Rating Between Baseline and First Clinic Visit
Unchanged - Clinically Relevant
54 participants
70 participants
Clinical Course Rating Between Baseline and First Clinic Visit
Resolved
2 participants
3 participants
Clinical Course Rating Between Baseline and First Clinic Visit
Improved
22 participants
29 participants
Clinical Course Rating Between Baseline and First Clinic Visit
Unchanged - Not Clinically Relevant
10 participants
20 participants
Clinical Course Rating Between Baseline and First Clinic Visit
Worse
6 participants
15 participants

Adverse Events

Teledermatology Referrals

Serious events: 2 serious events
Other events: 1 other events
Deaths: 0 deaths

Conventional Referrals

Serious events: 1 serious events
Other events: 2 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Teledermatology Referrals
n=196 participants at risk
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=196 participants at risk
Conventional consult process Conventional consult process: Standard electronic consult
General disorders
Death Unrelated to Study Participation
1.0%
2/196 • Number of events 2
0.51%
1/196 • Number of events 1

Other adverse events

Other adverse events
Measure
Teledermatology Referrals
n=196 participants at risk
Store and forward teledermatology consult process Store and forward teledermatology: Standard electronic consult, standardized history, and image set
Conventional Referrals
n=196 participants at risk
Conventional consult process Conventional consult process: Standard electronic consult
Skin and subcutaneous tissue disorders
Wound Dehiscence
0.00%
0/196
0.51%
1/196 • Number of events 1
Skin and subcutaneous tissue disorders
Rash from Sunscreen
0.51%
1/196 • Number of events 1
0.00%
0/196
Skin and subcutaneous tissue disorders
Infection at Biopsy Site
0.00%
0/196
0.51%
1/196 • Number of events 1

Additional Information

John D. Whited, MD, MHS

Department of Veterans Affairs

Phone: 919-286-6926

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place